Although there have not been in vitro results to prove the hypothesis, this finding suggests a novel mechanism for the interaction between COMT and ALDH2 in the pathogenesis of PD—development of neurotoxicity resulting from an imbalance in the pathway metabolizing monoamine neurotransmitter neurotoxic metabolites. The gene discussed is COMT; the disease is Parkinson disease.